Wellington Management Group’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,117
Closed -$654K 2422
2017
Q4
$654K Buy
1,117
+20
+2% +$12.9K ﹤0.01% 1998
2017
Q3
$809K Sell
1,097
-19,323
-95% -$16M ﹤0.01% 1946
2017
Q2
$17.7M Buy
20,420
+19,123
+1,474% +$16M ﹤0.01% 1068
2017
Q1
$1.1M Buy
1,297
+287
+28% +$238K ﹤0.01% 1898
2016
Q4
$770K Hold
1,010
﹤0.01% 1923
2016
Q3
$829K Sell
1,010
-10,992
-92% -$9.5M ﹤0.01% 1879
2016
Q2
$10M Sell
12,002
-10,983
-48% -$9.17M ﹤0.01% 1140
2016
Q1
$21.1M Sell
22,985
-140
-0.6% -$134K 0.01% 910
2015
Q4
$23.8M Buy
23,125
+19,107
+476% +$19.2M 0.01% 908
2015
Q3
$3.79M Sell
4,018
-1,175
-23% -$1.23M ﹤0.01% 1435
2015
Q2
$5.41M Buy
+5,193
New +$5.44M ﹤0.01% 1379

Other funds holding AGN.PRA

Wellington Management Group's AGN.PRA Position: Q1 2018 in Review

Wellington Management Group sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 1,117 shares — an estimated $654K sold.

Wellington Management Group first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $23.8M in Q4 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Wellington Management Group reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Wellington Management Group sold 1,117 Allergan plc shares in Q1 2018, an estimated $654K.
  • Wellington Management Group first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Wellington Management Group's Allergan plc position peaked at $23.8M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Wellington Management Group's 13F filing for Q1 2018, filed 15 May 2018.